110 citations
,
February 2024 in “Journal of Chemical Information and Modeling” This study describes the PandaOmics platform, which uses AI and bioinformatics to identify new therapeutic targets and biomarkers for various diseases, demonstrating validation in laboratory and animal studies.
17 citations
,
April 2023 in “Aging” In this study, the authors used AI-driven methods to identify and prioritize promising therapeutic targets that may address both aging and Glioblastoma Multiforme, proposing CNGA3, GLUD1, and SIRT1 as novel candidates.
1 citations
,
February 2025 in “International Journal of Scientific Research and Management (IJSRM)” This article examines challenges in the pharmaceutical supply chain during pandemics, highlighting issues like raw material sourcing and distribution delays, and suggests enhancements such as AI, blockchain, and public-private alliances to ensure stability and resilience.
1 citations
,
September 2025 in “The Yale Journal of Biology and Medicine” This essay explores the similarities in long-term health impacts of the COVID-19 and 1918 influenza pandemics, emphasizing how understanding medical history can guide better responses to post-epidemic health issues.
11 citations
,
May 2021 in “Journal of Ovarian Research” This review discusses how high estrogen levels in African women might contribute to lower COVID-19 rates and fatalities, reports no new clinical results, and suggests considering these factors for future pandemics.